Found: 4
Select item for more details and to access through your institution.
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 10, doi. 10.3390/cancers11010010
- By:
- Publication type:
- Article
Everolimus plus exemestane as first-line therapy in HR, HER2 advanced breast cancer in BOLERO-2.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 3, p. 459, doi. 10.1007/s10549-013-2814-5
- By:
- Publication type:
- Article
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 654, doi. 10.1093/jnci/djt026
- By:
- Publication type:
- Article
Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 5, p. 295, doi. 10.1159/000350625
- By:
- Publication type:
- Article